WEDNESDAY, April 4, 2018 — Testicular cancer survivors (TCS) have metabolic abnormalities characterized by hypertension and increased low-density lipoprotein (LDL) and total cholesterol, according to a study published in the March 1 issue of the Journal of the National Comprehensive Cancer Network.
Mohammad Abu Zaid, M.D., from Indiana University in Indianapolis, and colleagues examined clinical and genetic metabolic syndrome (MetS) risk factors in 486 North American TCS aged <55 years at diagnosis and who received first-line chemotherapy.
The researchers found that, compared with controls, TCS had a higher prevalence of hypertension (43.2 versus 30.7 percent; P < 0.001), but they were less likely to have decreased high-density lipoprotein (HDL) cholesterol levels (23.7 versus 34.8 percent; P < 0.001) or abdominal obesity (28.2 versus 40.1 percent; P < 0.001). The frequency of MetS was similar in TCS and controls (21.0 versus 22.4 percent; P = 0.59), with no difference by treatment (P = 0.20) and no correlation with rs523349 (5-α-reductase gene SRD5A2; P = 0.61). TCS were significantly more likely to have increased LDL cholesterol levels (P < 0.001), total cholesterol levels (P < 0.001), and body mass index ≥25 kg/m² (P = 0.04). There were significant associations for age at evaluation, testosterone level ≤3.0 ng/mL, and elevated soluble cell adhesion molecule-1 level with MetS.
“Metabolic abnormalities in TCS are characterized by hypertension and increased LDL and total cholesterol levels but lower rates of decreased HDL levels and abdominal obesity, signifying possible shifts in fat distribution and fat metabolism,” the authors write.
© 2018 HealthDay. All rights reserved.
Posted: April 2018
November 13, 2018
November 12, 2018
- FDA Approves Keytruda (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
- Scientists take big step toward finding non-addictive painkiller
- Diabetes medication reduces risk of heart failure hospitalization
- Achieving high follow-up rates for violently injured patient population is feasible
- Shortage of specific gene ‘silencing’ molecules linked with pediatric low-grade gliomas
- Abx-Resistant Enterobacteriaceae Tied to Clinical Failure in UTI
- US approves first new type of flu drug in 2 decades
- Is zinc the link to how we think? Some evidence, and a word of warning
- Dispelling taboos, Michelle Obama talks IVF and miscarriage
- Medical experts discuss future challenges of healthcare at HSMA’s inaugural conference
- Growth and spread of deadly eye tumor suppressed in cells, animals
- Study finds huge shortfall in use of home-based medical care by frail seniors
- Cocaine Cut With Anti-Worming Drug, Levamisole, May Cause Brain Damage
- Obese mice lose a third of their fat using a natural protein
- Behind many a Parkinson’s case lurks a mutation in a gene called LRRK2 — why?
- Drug with fish oil cuts risk of heart attack, stroke, study finds
- Mild exposure to single blast can induce meaningful pathogenic effects, study shows
- Miniature pacemakers aim to make heart procedures for infants less invasive, more efficient
- Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer
- Kawasaki disease triggered by a combination of factors